Tracking safety of pulmonary hypertension medicines by computer follow-up
Part of Heart & circulation, Lungs & breathing clinical trials.
This study checks how safe pulmonary hypertension–targeted medicines (and some calcium-blocking medicines) are over time. It uses a computer system to follow you after diagnosis, looking at outcomes and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 months and 85 years old
- A right-heart catheter test shows your pressures fit the study targets (mPAP at least 25 and PAWP 15 or less)
- Your lung/heart pressure pattern suggests pulmonary hypertension groups 1, 2, 4, or 5 (as defined by the study’s WHO categories)
- You take at least one pulmonary hypertension–targeted drug or a calcium antagonist
- You have signed written consent (or a guardian has signed for a child)
- You do not have pulmonary hypertension caused by left-heart (heart pump/valve) problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information on people with pulmonary hypertension who are using or starting targeted medications. The goal is to understand how these treatments work in real-world settings and improve care for patients like you.
This study tests whether a home-based exercise program, guided by a smartphone app, can improve your daily life and heart function if you have pulmonary hypertension. You will use a wearable device to track your activity and receive remote support from a medical team.
This study is tracking people with pulmonary hypertension (high blood pressure in the lungs) over time to see how their condition and quality of life change. By joining, you help doctors better understand the disease and improve care for others like you.
This study aims to better predict the future risk for people with pulmonary hypertension (high blood pressure in the lungs) by combining different types of health information collected over time. If you join, researchers will track your health data to build a tool that personalizes care and improves outcomes.
This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.
This study is testing whether a new risk score can better predict outcomes for people who have both chronic lung disease and pulmonary hypertension (high blood pressure in the lungs). If you qualify, the researchers will follow your health over time to see how well the score works.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.